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Abstract
Background: Infectious bursal disease virus (IBDV) is a pathogen of worldwide significance to the poultry industry. IBDV has
a bi-segmented double-stranded RNA genome. Segments A and B encode the capsid, ribonucleoprotein and non-structural
proteins, or the virus polymerase (RdRp), respectively. Since the late eighties, very virulent (vv) IBDV strains have emerged in
Europe inducing up to 60% mortality. Although some progress has been made in understanding the molecular biology of
IBDV, the molecular basis for the pathogenicity of vvIBDV is still not fully understood.
Methodology, Principal Findings: Strain 88180 belongs to a lineage of pathogenic IBDV phylogenetically related to vvIBDV.
By reverse genetics, we rescued a molecular clone (mc88180), as pathogenic as its parent strain. To study the molecular
basis for 88180 pathogenicity, we constructed and characterized in vivo reassortant or mosaic recombinant viruses derived
from the 88180 and the attenuated Cu-1 IBDV strains. The reassortant virus rescued from segments A of 88180 (A88) and B
of Cu-1 (BCU1) was milder than mc88180 showing that segment B is involved in 88180 pathogenicity. Next, the exchange of
different regions of BCU1 with their counterparts in B88 in association with A88 did not fully restore a virulence equivalent
to mc88180. This demonstrated that several regions if not the whole B88 are essential for the in vivo pathogenicity of 88180.
Conclusion, Significance: The present results show that different domains of the RdRp, are essential for the in vivo
pathogenicity of IBDV, independently of the replication efficiency of the mosaic viruses.
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Introduction
Infectious bursal disease virus (IBDV) is a pathogen of
worldwide significance to the poultry industry. IBDV destroys
the immature B lymphocytes in the bursa of Fabricius (BF) of
chickens, thus causing immunosuppression, and clinical disease
mainly occurs between 3 and 7 weeks of age [1]. Since the late
eighties, very virulent (vv) IBDV strains have emerged in Europe
inducing up to 60% mortality [2–4].
IBDV is a bisegmented double stranded (ds) RNA virus
belonging to the family Birnaviridae,g e n u sAvibirnavirus [5].
Genome segment A (3,2 kbp) encodes in a large open reading
frame (ORF) a precursor polyprotein which is cleaved by
autoproteolysis to yield i) the outer capsid, VP2, the maturation,
tri dimensional structure and major immunogenic determinants
of which have been described [6–9], ii) the virus protease, VP4
[10,11] and iii) an internal protein, VP3, that binds to viral
dsRNA to form ribonucleoprotein complexes [12]. From a small
ORF preceding and partially overlapping the large ORF,
segment A also encodes VP5, a non structural protein [13]
possibly involved in virus release [14–16] and/or inhibition of
apoptosis at early stages of infection [17]. Genome segment B
(2,8 kbp) encodes the virus RNA dependent RNA polymerase
(RdRp or VP1) [18], the polymerase activity of which has been
unequivocally characterized in vitro [19]. The RdRp is also
present in virus particles as a genome linked protein (VPg) [20].
The recently determined tri-dimensional structure of the IBDV
RdRp showed that the polypeptide chain can be divided into
three domains: i) an N-terminal domain (residues 1–167) ii) the
central polymerase domain (residues 168–658) which contains the
‘‘Fingers’’, ‘‘Palm’’ and ‘‘Thumb’’ subdomains and iii) aC -
terminal domain (residues 659–878) [21,22]. The comparison of
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Sthe tri-dimensional structure and the aminopeptidic sequence of
IBDV VP1 with RdRp of other RNA viruses [21–24], including
IPNV [25], allowed to identify eight amino acids motifs supposed
to be essential for the biological activity of IBDV RdRp. These
motifs include the putative self-guanylylation site of IBDV RdRp
in the N-terminal domain of the polymease [25,26]. The 7 others
motifs are present in the central domain of the polymerase and
are suggested to be involved in the nucleotide recognition and
binding (motif A, B and F), phosphoryl transfer (motif A and C),
control of metal dependence (motif C), structural integrity of the
palm (motif D), priming nucleotide binding and proper
positioning of the ‘‘Thumb’’ relative to the ‘‘Palm’’ (motif E),
and template binding (motif B, F and G) [21–23,27–34].
Interestingly, the C motif was found to be in a permuted position
in the RdRp of Birnaviridae as compared with other viral RdRps
[21–24] which could be linked with an unusual Co
2+ dependence
of this polymerase [34].
Although some progress has been made in understanding the
molecular biology of IBDV, the molecular basis for the
pathogenicity of vvIBDV is still not fully understood. The study
by reverse genetics of the genes or genomic regions of vvIBDVs
involved in pathogenicity is particularly challenging because these
viruses are not adapted to cell culture. Currently, the vvIBDV
phenotype is still largely defined by a significantly increased
mortality following challenge. Segment A-encoded proteins do
play a role, as demonstrated by reverse genetics studies where a
mosaic classical virus containing the VP2 of a vvIBDV strain did
induce lesions of the BF. However the mosaic virus failed to induce
either morbidity or mortality in young chickens, thus demonstrat-
ing that VP2 of vvIBDV was not the sole determinant for their
pathogenicity. In addition, the introduction of VP4 or VP3 of a
vvIBDV into the genetic background of a classical virus did not
confer any pathogenicity [35]. Another study with interserotypic
reassortant viruses generated by reverse genetics confirmed that
segment A of serotype 1 IBDV was responsible for the bursa
tropism [36].
The literature regarding the influence of segment B on IBDV
phenotype reveals somewhat conflicting results. It was suggested in
an early study that segment B of vvIBDV has a limited influence
on pathogenicity [35]. However, other studies showed that
segment B of a vvIBDV, a variant or a vaccine IBDV strain
could influence the replication efficiency and modulate the bursal
lesions [36–38]. The latter hypothesis seems consistent with the
phylogeny-based assertion that both genome segments may be
involved in IBDV pathogenicity [39] and with the observations
that naturally occurring reassortant IBDVs with either a vvIBDV-
related segment A but an unrelated segment B [40], or the
converse genetic make up (classical segment A with vvIBDV-
related segment B, [41,42], exhibit a reduced or increased
pathogenicity, respectively. A chrono-phylogenetic study also
suggested that the worldwide expansion of vvIBDV likely started
following the acquisition of a new vvIBDV-related segment B,
whereas the vvIBDV-related segment A could have been
introduced several years earlier [43].
In the present study, we investigated the molecular basis for the
pathogenicity of IBDV strain 88180, previously characterized in
our laboratory as the only known representative of a lineage of
pathogenic IBDV with significant phylogenetic relationships to
vvIBDV [40,44]. We used the reverse genetics approach
developed by Mundt and Vakharia [45] to construct infectious
cDNA copies of the 88180 genome. These plasmids allowed the
rescue of mc88180, a molecular clone with the same pathogenicity
as its parental strain. In order to investigate the molecular basis of
pathogenicity in mc88180, the plasmids were then used in reverse
genetics to construct reassortant or intra segment B mosaic viruses
derived from the mc88180 and the attenuated Cu-1 IBDV strains.
Our results confirm that both genome segments are important for
a full pathogenicity and further demonstrate that several (if not all)
regions within segment B are also required.
Results
The two genome segments of 88180 are more related to
their counterparts in vvIBDVs than to the attenuated
Cu-1 strain
Because this study provided the first full length sequences of an
IBDV isolate belonging to an original genetic lineage [44], the nt
or aa sequences (for non coding [NCR] and coding regions,
respectively) of the full-length segments A or B segments of the
bursa derived 88180 strain were compared in detail with their
counterparts in the attenuated Cu-1 strain [36] and in typical
vvIBDV D6948 strain (Table 1).
In segment A, the sequence of the 59 NCR of 88180 exhibited 4
or 5 nt changes as compared with Cu-1 or D6948, respectively.
The overall predicted secondary structure of the A59NCR was
more similar with that of Cu-1 and one nucleotide change found in
88180 (44C) restored a predicted stretch of paired nucleotides (nts
10 to 16, base-paired with nts 40 to 46) also predicted in D6948
(data not shown). The predicted VP5 protein of 88180 (4 and 7 aa
differences with Cu-1 and D6948, respectively) was four aa shorter
than in D6948 at its N-terminal extremity, as also found in Cu-1,
and exhibited several aa changes in its putative cytoplasmic
domain. In the predicted polyprotein, the VP2 precursor (pVP2) of
88180 differed from Cu-1 and D6948 at 13 and 6 aa positions,
respectively. All but one of these changes were located in the so-
called ‘‘antigenic domain’’ of VP2, and 3 of the differences
observed with D6948 affected aa positions conserved in typical
vvIBDV (A222, I294 and S299). The only other change (L451RI,
observed in Cu-1) affected the pep46 peptide released upon the
maturation process of VP2. The deduced VP4 protein of 88180
was much similar with VP4 of D6948 (only one aa change), but
exhibited 6 aa changes as compared with Cu-1, two of these
changes (aa 541 and 751) occurring in regions of the protease
possibly important for the cleavage at the VP4-VP3 and pVP2-
VP4 junctions, respectively. VP3 of 88180 exhibited 1 aa change
as compared to its D6948 counterpart in the putative RNA-
fixation site (aa 990) and 3 aa changes as compared with Cu-1.
Two of the 3 latter changes (aa 981 and 990) were present in the
putative RNA-fixation site and one (aa 1005) in the VP1
interaction site. Finally, nts changes occurring in the 39NCR of
segment A did not appear to cause drastic changes in the predicted
secondary structure of the NCR (data not shown).
In segment B, the 59 NCR of 88180 exhibited 6 and 3 nt
changes as compared with Cu-1 and D6948, respectively. None of
these combinations of changes modified the predicted secondary
structure of the NCR. Interestingly, this structure included the
base-pairing of nts 53–56 with nts 62–65, hence forming a hairpin
structure close to a terminal loop, and base-pairing was
maintained at these positions although both nts of the 55–63 pair
were modified in Cu-1 (being C-G, as compared with T-A in
88180 or D6948). This suggests that the secondary structure at this
position could be important for the function of the B59 NCR.
Comparison of the VP1 aa sequence of the three viruses revealed
23 aa differences between Cu-1 and 88180, and 11 differences
between 88180 and D6948. In both comparisons, most amino acid
changes were quite evenly distributed along the ORF, however
both pairs of viruses exhibited aa differences located close to the
catalytic domain of VP1 (changes aa positions 390–391 and 391–
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between 88180, Cu-1 and typical vvIBDV strain D6948 (Acc No AF240686 and AF240687 for segments A and B, respectively).
Segment A Segment B
Nt or aa
position Cu-1 88180 D6948 Gene or region
Nt or aa
position Cu-1 88180 D6948 Gene or region
44 t c 59NCR 55 c t 59NCR
45 c t 58 t a t
47 t a 59 a g
69 g a 60 a t c
78 t c t 63 g a
79 t a t 69 g a
86 c t 106 g a
21- - M VP5 4I V Domain 1 (N-ter; F1)
22- - L 1 3 TK
23- - S 3 5 RK
24- - L 4 1 VI E
14 K E 55 K R
34 N H N 145 N T
45 G R 146 E D
74 I F 147 G S N
125 S P 219 D N D
133 R W 242 D E
222 P Q A pVP2 287 T A
242 V I 305 S N S
253 H Q 390 L M Catalytic domain (P1-F2-P2)
256 V I 391 A T A
257 L M L 393 E D
270 T A 508 R K Domain 2 (P2-T-C-ter)
279 N D 511 R S
284 T A 546 L P
294 L I 562 S F P
297 S P 576 T A T
299 N S 595 C S C
300 E Q E 646 G S
330 R S 687 S P
334 A V A 695 K R
451 I L 756 K R K
541 V I VP4 879 - Q
680 C Y 2749 c t 39NCR
685 K N 2786 t c
691 A T 2827 - c -
713 A T
715 P S
751 H D
981 L P VP3
990 A V A
1005 T A
3168 a g 39NCR
3205 t c
3224 t g a
3229 c a
3231 t a
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that had been previously reported to be unique and common to all
vvIBDV [39], five were conserved in 88180 (D146, E242, M390,
P687, R695), but three were modified in this virus N147RS,
D393RE and P562RF) (see asteriks in Figure 1 C). Finally, the
39NCR of B88 had the same nt sequence as its D6948 counterpart
Segment A Segment B
Nt or aa
position Cu-1 88180 D6948 Gene or region
Nt or aa
position Cu-1 88180 D6948 Gene or region
3261 t c -
3262 - c -
The 88180 sequence was used as a reference and only nucleotides or amino acids differences were presented. Italicised letters indicate positions that have been
reported to be typical of vvIBDV, in VP2 and VP1. For the segment A, in the left column, 21, to 24 numbers correspond to the presence of four additional amino acids
in the VP5 protein of the typical vvIBDV strain D6948 (153 aa long) compare to 88180 or Cu1 strains (149 aa long). In the second large ORF partly overlapping VP5, pVP2
corresponds to aa 1 to 512, VP4 to aa 513 to 755 and VP3 to aa 756 to 1012. For the segment B (878 aa), domain 1 contains the N-terminal domain (N-ter) and Finger 1
(F1) subdomains, the catalytic domain contain the Palm 1 (P1), Finger 2 (F2) and Palm 2 (P2) sub-domains and domain 2 contains the Palm 2 (P2), Thumb sub-domains
(T) and the C-terminal region (C-ter) as determined from the tridimensional structure of the IBDV polymerase recently solved [21,22].
doi:10.1371/journal.pone.0028064.t001
Table 1. Cont.
Figure 1. Organisation of IBDV segment B and construction of mosaic B segments derived from pB88 and pBCU1. A) Position of the
motifs involved in the biological activity of IBDV RdRp. The first double arrow (aa 1 to 175) shows the possible region where the self-guanylylation site
(Gs) of IBDV RdRp is predicted to be positioned [26]. The 7 others motifs (G, F, C, A, B, D and E) are present in the central domain of the polymerase
and are suggested to be involved in the nucleotide recognition and binding (motif A, B and F), phosphoryl transfer (motif A and C), control of metal
dependence (motif C), structural integrity of the palm (motif D), priming nucleotide binding and proper positioning of the ‘‘Thumb’’ relative to the
‘‘Palm’’ (motif E), and template binding (motif B, F and G) (see text for references). The second double arrow indicates the domain of VP1 interacting
with VP3 [55]. Finally, aa 371 to 499 have been defined as a region with alternating b layers and a helixes corresponding to the Palm 1 and Finger 2
region delimiting the catalytic domain. B) The tri-dimensional structure of the IBDV RdRp recently solved allowed to determine that the polypeptide
chain can be divided into three domains: i) an N-terminal domain (residues 1–167) surrounding ii) the central polymerase domain (residues 168–658)
which contains the ‘‘fingers’’ (F1 and F2), ‘‘palm’’ (P1 and P2) and ‘‘thumb’’ (T) subdomains and iii) a C-terminal domain (residues 659–878) [21,22]. C)
Segment B of 88180 cloned into the pUC18 plasmid under the control of the T7 promotor (horizontal black triangle). The position of nts (NCRs) or aa
(coding region) that differentiate 88180 from pBCU1 or D6948 are indicated by short black vertical bars appearing below or above the plasmid,
respectively. Asterisks identify conserved aa typical of vvIBDV [39] that are modified in 88180. White vertical triangles indicate the position of unique
and conserved enzymes restrictions sites used for the construction of pBCU1/pB88 mosaic plasmids. D) The two regions of IBDV VP1 (D1 and D2)
surrounding the catalytic domain (DC) considered for the construction of mosaic segment B, together with the aa position of their boundaries. E) The
constructed mosaic B segments. Black and opened areas represent genome regions derived from pB88 and pBCU1, respectively. See in text the
method of construction.
doi:10.1371/journal.pone.0028064.g001
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predicted structure of the B39 NCR in Cu-1 exhibited some
differences due to the C2786RT nucleotide change.
The nt sequences of the A and B genome segments of 88180
were finally compared, using phylogenetic methods, with their
counterparts in a panel of vvIBDV and classical strains retrieved
from databanks [46]. This phylogenetic study confirmed that the
segments A and B of 88180 are both phylogenetically related to,
but nevertheless significantly different from, vvIBDV (data not
shown).
mc88180 exhibits the same phenotype as its parental
88180 strain
The antigenicity of mc88180 was first compared with that of the
88180 virus. Both viruses exhibited the same antigenic profile as
previously reported (with a lack of binding of monoclonal
antibodies [Mabs] 3 and 4 and a strong reactivity of all other
Mabs) [44], thus showing that the aa change introduced in
mc88180 at VP2 aa position 281 does not alter the virus reactivity
with the studied Mabs (data not shown).
The pathogenicity of mc88180 was then compared under
standardized experimental conditions with that of IBDV strains
88180, F52/70 and 89163, the two latter strains being used as
controls selected for their typical classical or vv IBDV phenotypes,
inducing 5–20% and 20–60% mortality under the studied
experimental conditions, respectively (Figure 2). Neither clinical
signs nor mortality were observed in the mock-inoculated control
group which remained seronegative throughout the experiment.
In the groups receiving the challenge viruses, typical signs of acute
IBD (diarrhoea, prostration, ruffled feathers) were observed from 3
to 7 days post inoculation (DPI) and mortality occurred from 3 to
5 DPI (Figure 2 A). The Chi-square test showed that mortalities
induced by the mc88180 (27%), 88180 (23%) and 89163 (30%)
viruses did not differ significantly but were significantly higher
than that induced by the F52/70 challenge (7%). The only other
difference between the four inoculated viruses was in the titer of
virus recovered from the bursae sampled at 4 DPI (Figure 2F), as
89163 resulted in 10
8.2 EID50/g whereas the three other viruses
yielded comparable and significantly lower virus titers (10
6.4,1 0
6.0,
and 10
5.7 EID50/g for the mc88180, 88180 and F52/70 viruses,
respectively). None of the other observed criteria (mean bursa-to-
body weight [b/B] ratio, mean bursal lesion score [BLS] at 4 and
17 DPI, and geometric mean VN titer at 17 DPI, Figure 2B, C, D
and E) did reveal any significant difference between the four
challenged groups. Altogether, these results suggested that
mc88180 indeed induced the same acute pathogenicity as the
parental 88180 strain.
Both segments of mc88180 are essential for a full
pathogenicity
In order to investigate which segment of mc88180 was involved
in pathogenicity we produced by reverse genetics the mcCu-1
virus and the two reassortant viruses derived from mc88180 and
mcCu-1, namely A88 BCU1 and ACU1 B88 (Suplementary Table
S1). All viruses were inoculated under standardized experimental
conditions to 7-week-old SPF chickens. Results of this experiment
are presented in Figure 3.
Neither signs nor mortality were observed in the mock-
inoculated control group. Morbidity was observed from 3 to
5 DPI: mc88180 induced 100% morbidity, A88BCU1 40%
(p#0.001 as compared with mc88180), ACU1B88 5% and
mcCu-1 0%. The two latter groups did not differ significantly
with respect to morbidity, but differed significantly (p#0.05) from
both mc88180 and A88BCU1 (data not shown). Only mc88180
induced mortality, although at a lower rate than in the previous
experiment (5%) (Figure 3A).
Analysis of the other criteria (see Figure 3 B, C, D, E and F)
confirmed that the mock-inoculated control group remained
uninfected throughout the experiment, and that the molecularly
cloned viruses performed consistently with the phenotype of their
parent viruses. Indeed, mcCu-1 replicated well in the bursa
(genome amounts equivalent to 10
5.361.6 EID50/g detected in
qRT-PCR, Figure 3F), induced significant but limited bursal
lesions (mean b/B ratio and BLS at 20 DPI=1.560.6% and
1.460.5, respectively, Figures 3B and 3C) and proved highly
immunogenic (mean VN titer at 20 DPI=11.561.3 log2,
Figure 3E), in agreement with Zierenberg et al. (2004) [36]. As
also expected, mc88180 replicated in the bursa to a similar extent
(10
5.860.3 EID50/g detected in qRT-PCR) and proved both highly
pathogenic (inducing the smallest mean b/B ratio at 20 DPI,
0.560.1%, and the highest BLS at both 4 and 20 DPI, 4.060.0
and 3.260.4, respectively) and immunogenic (mean VN titer
11.661.3 log2). The two reassortant viruses exhibited markedly
different properties. On the one hand, ACU1B88 replicated to a
significantly lower extent in the bursa (10
3.760.7 EID50/g detected
in qRT-PCR, p=0.013), it hardly induced any bursal lesion (no
significant difference in b/B ratio or in BLS with uninfected
controls, irrespective of the sampling date) and proved poorly
immunogenic (highly heterogeneous VN titers at 20 DPI, ranging
,3.3 to 11.1). These results suggested an infectivity even lower
than that of mcCu-1 which induced significantly more bursal
atrophy, histological lesions and antibodies at 20 DPI (see above,
p#0.05). On the other hand, A88BCU1 replicated as well as the
mc viruses (10
5.560.3 EID50/g detected in qRT-PCR) and induced
marked bursal atrophy (mean b/B ratio at 20 DPI=0.7+0.2%),
severe histological lesions (mean BLS at 4 and 20 DPI=3.460.5
and 2.860.4, respectively) and high levels of antibodies (geometric
mean VN titer=9.262.3 log2).
Taken together, our results showed the low compatibility of the
segment A of CU1 with the segment B of 88180 and also
confirmed the paramount role of segment A in the pathogenicity.
However, all criteria but the virus titer indicated also a slight but
significant (p#0.05) reduction of the pathogenicity of A88BCU1
as compared with mc88180 (Figure 3), in agreement with the
reduced morbidity observed at 4 DPI. These results showed that
segment B of 88180 is also involved in the pathogenicity of
mc88180.
The association of several regions of segment B of 88180
is required for pathogenicity
The critical role of segment A and domains of this segment
involved in vvIBDV pathogenicity was previously investigated
[35]. However, the domains of the IBDV polymerase involved in
virulence remain unknown. To investigate which regions of the
segment B of A88BCU1 could be responsible for this virus reduced
pathogenicity, we tried to restore it in recombinant mosaic IBDVs
in which the A88 background was kept but different regions of
segment B of CU1 were replaced with their counterparts in B88
(Figure 1). Five mosaic B segments were constructed (Figure 1E)
and the resulting viruses were rescued (Table S1) and investigated
in vivo for their pathogenicity as before. As in the previous
experiments, the mock-inoculated group kept uninfected through-
out the experiment. Calculation of a newly designed mean
symptomatic index (see materials and methods) showed that
mc88180 (maximum mean symptomatic index=2.6 at 4 DPI)
induced significantly more morbidity than all other viruses (mean
symptomatic index=0.2 to 0.5 at 4 DPI, p#0.0001) (Figure 4).
RNA Polymerase Domains Involved in IBDV Virulence
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p#0.003), whereas no significant difference in the severity of
clinical signs was observed between the groups receiving the other
viruses or mock-inoculated. Once again, only mc88180 induced
mortality (15%, no significant difference with 0% observed in
other groups, Figure 5A).
At 4 DPI, the seven inoculated groups did not differ
significantly by their mean BLS (ranging 3.260.4 to 4.060.0,
Figure 5C) and by the amounts of virus genome detected in BF
(equivalent to virus titers ranging 10
5.660.5 to 10
6.160.6 log10
EID50/g, Figure 5F), thus showing that all the viruses with a
mosaic segment B replicated well in the bursa. At 21 DPI, no
significant difference in the antibody levels were observed in the
birds inoculated with the seven viruses (Figure 5E). The chickens
inoculated with B88[D2CU1] seemed to experience a quicker
recovery than the other groups, as illustrated by significantly
higher b/B ratio (1.460.6%, Figure 5B) and significantly lower
BLS (2.460.5, Figure 5D) at 21 DPI than in the other inoculated
groups, which did not differ significantly one to another (mean b/
B ratios ranging 0.760.5 to 1.060.2% and mean BLS ranging
3.060.0 to 3.260.4, p#0.05).
Discussion
As an attempt to investigate the molecular basis for IBDV
pathogenicity, mc88180, the molecular clone of a vvIBDV-related
pathogenic IBDV strain [40,44] was rescued from plasmid copies
of both genome segments.
The mc88180 virus was shown to exhibit the same phenotype as
its parental 88180 strain, as demonstrated by a similar antigenic
reactivity and ability to induce morbidity and mortality. However,
some variation in the mortality induced by mc88180 was observed
in our three animal experiments, as the mc88180-induced
mortality ranged 5 to 27% (no statistically significant difference
according to the Chi-squared test). Although mortality in the first
experiment (27%) did not differ significantly from that induced by
the 89163 vvIBDV control virus (30%), the percent mortality
observed in subsequent experiments was lower than would have
been expected in our experimental model for a typical vvIBDV
[44,47,48]. Whether some genetic specificities of 88180 might be
associated with a reduced pathogenicity as compared with
vvIBDV will be discussed below. The variation in successive
experiments cannot be explained by the source of the SPF
chickens (AFSSA-Ploufragan), nor by their age (as they had been
selected around the maximum susceptibility age of 6 weeks), nor
by the virus titers in the mc88180 inoculum (which was the same
virus suspension). However, the sequencing of the virus pools
recovered from the BF of chickens succombing to mc88180-
infection in each experiment showed that in experiment i) only, a
mixed virus population was detected. Indeed, at aa position 281,
the virus pool contained the Glutamic acid used as a genetic tag
for mc88180 as well as the Glycin corresponding to the aa found in
wild-type 88180. This result shows that mc88180 partly reverted
to the wild-type sequence in experiment i), which could explain
the highest pathogenicity of mc88180 observed in this specific
experiment. Further studies would be required to assess precisely
the role of aa 281 in 88180 pathogenicity. Whatever this may be,
the intensity of the clinical signs induced by mc88180 in the
successive experiments was enough to investigate the role of the
segments A and B in the pathogenicity of 88180, by comparison
with the attenuated Cu-1 virus.
Complete sequencing of genome segments A and B of IBDV
strain 88180 revealed that both genome segments are related to
their counterparts in vvIBDV but are nevertheless significantly
different. This result confirmed previous analysis performed on
partial sequences from this virus strain [40,44]. Several genetic
traits differentiate the 88180 virus from the typical vvIBDV. One
of these is a shorter VP5 gene, the longer VP5 gene observed in
vvIBDVs (4 more codons in the 59end of the VP5 ORF as
compared with Cu-1 or 88180) being due to the putative start
codon being located upstream in vvIBDVs and resulting in a
longer VP5 cytoplasmic domain in typical vvIBDVs) [35]. This
difference did not appear to be a critical determinant for
pathogenicity, as mc88180 proved as pathogenic as strain
89163, our vvIBDV control, in the first experiment. A second
major difference between 88180 and vvIBDV affects the VP2
protein. It has been observed that all vvIBDV identified to date
share the four vvIBDV-specific VP2 aa positions A222, I256, I294
and S299 [49]. Of these, only I256 is present in 88180. Finally,
eleven aa changes scattered along the VP1 protein also differ
between 88180 and vvIBDV (Table 1). Three of these differences
were located at aa positions 147, 393 and 562, which have
otherwise been suggested to be conserved in all vvIBDV [39]. The
multiplicity of these differences did not allow to pinpoint any
particular region of the genome as responsible for the differences
in pathogenicity between 88180 and typical vvIBDVs, which is the
reason why in the second part of the study mosaic viruses were
constructed instead of correction by site-directed mutagenesis of
single mutations.
Reassortant viruses derived from mcCu-1 and mc88180 were
constructed in order to check whether some genome segments or
the compatibility between the segment A- and segment B- encoded
proteins could be major determinants of the 88180 pathogenic
phenotype. Although A88BCU1 apparently replicated to the same
extent as mc88180, we observed in two independent animal
experiments that this virus was significantly less pathogenic than
mc88180 (no mortality and a significantly lower morbidity were
observed with A88BCU1, the latter observation led to the
development of a symptomatic index implemented in the last
experiment to quantify IBD signs). This suggests that BCU1
played a role in the reduced pathogenicity of this reassortant virus.
This hypothesis is in agreement with a previous study by our group
showing that a naturally occurring reassortant virus, with a
vvIBDV-derived segment A and an unrelated segment B, had a
reduced pathogenicity in spite of a replication ability at 4 DPI
similar to that of pathogenic IBDVs [40]. The assumption that
Figure 2. Compared pathogenicity of recombinant or wild type IBDV strains mc88180, 88180, F52/70 and 89163 in six-week old
SPF chickens (experiment i). On the first day of the experiment, SPF chickens were housed in five groups of 30 chickens of comparable sex and
weight. On the same day, each bird was inoculated by the intranasal route with a standardized dose of the relevant virus (10
5 EID50 by bird). A group
was kept as a mock-inoculated control receiving PBS only. See in Table S3 the summarized protocol of the animal experiment. A) % cumulated
mortality at 5 days post infection, B) BF to body weights ratio (%) at day 17 (n=21 to 25 chickens depending on the group). The box plots show the
median (horizontal line) flanked by the 2
nd and 3
rd quartile. The outer bars show the range of values. C) and D) Histological lesion scoring at day 4
and 17, respectively (n=5 to 6 chickens per group). The outer bars show the range of values. E) VN titer at day 17 (in log2, n=21 to 25 chickens
depending on the group). F) virus titer at day 4 post infection (in log10 EID50/gr, n=5 chickens per group). Treatments sharing the same lowercase
letter do not differ significantly according to the kruskal-Wallis test (BF to body weights ratio, lesion score, VN titer and virus titer) or according to the
Chi-squared test (% mortality), at the p#0.05 confidence level.
doi:10.1371/journal.pone.0028064.g002
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does not reduce the replication ability is somewhat in contrast with
a previously published study suggesting that segment B of vvIBDV
was not involved in pathogenicity [35], and with subsequent work
by the same group suggesting that replacement of the segment B of
a vvIBDV strain by its counterpart in a cell-culture adapted virus
causes attenuation of the resulting reassortant, due to a delayed
replication [38]. However, the experimental conditions (different
source of SPF chickens and markedly reduced age at challenge
and challenge dose in Boot et al., 2005 [38]) could explain these
differences.
mc88180 and A88BCU1 but not ACU1B88 induced morbidity,
mortality (at least for mc88180), and severe bursal lesions. This
suggests that segment A of 88180 played a critical role in
determining the pathogenicity of the reverse genetics-generated
viruses. This is unlikely to be linked to bursa tropism only, as
ACU1 has also been shown previously to confer the ability to
replicate in bursal cells [36]. However, ACU1 encodes VP2 aa
253H, 279N and 284T which have been shown in various
combinations both to confer the ability to replicate in chicken
embryo fibroblasts [50–54], and to result in the attenuation of cell-
culture-adapted viruses [53,54]. Our results are hence consistent
with the assumption that segment A of 88180 carries the major
determinants for pathogenicity, as suggested in vvIBDVs by Boot
et al. [35] and van Loon et al. [53]. Whether these determinants
lie in those aa that are conserved in vvIBDVs and 88180, such as
VP2 aa position I 256 will deserve further study.
In addition to the predominant role of segment A88 in
pathogenicity, our results also demonstrated the limited compat-
ibility of segments ACU1 and B88. Indeed, reassortant virus
ACU1B88 was not pathogenic (as mentioned above, segment
ACU1 most likely played a role in this lack of pathogenicity) and
replicated poorly as compared with all other viruses inoculated in
the same experiment. This low replication capacity was already
apparent at the rescue step. It could not be improved by one
further passage of this virus on SPF chickens (data not shown),
which explains why the ACU1B88 challenge in experiment ii) was
performed with the original low-titer virus stock. As both the
mcCu-1 and mc88180 replicated well in the bursa of the
inoculated chickens in the same experiment, the lower replication
of ACU1B88 cannot be attributed to a single genome segment, but
rather to a low segment compatibility. A lower or delayed
replication capacity has also been described in laboratory
constructed reassortant IBDV, either derived from the Cu-1 and
the serotype 2 23/82 strains [36] or from the variant GLS-TC
(tissue culture adapted) and variant GLS-BD (Bursa adapted)
strains [37], or between vvIBDV strain D6948 and cell culture
adapted CEF94 [35,38]. Impairment of replication could be due
to the disruption of some interactions described to occur between
both genome segments and/or the proteins they encode. Indeed,
VP1 is known to interact with VP3 [55–57], and comparison of
the aa sequence of the Cu-1 and 88180 proteins reveals that one
out of three and twelve out of 23 aa differences do occur in the
interaction domains identified in VP3 and VP1, respectively.
Figure 3. Compared pathogenicity of mc88180, mcCu-1, A88BCU1 and ACU1B88 in seven-week old SPF chickens (experiment ii). On
the first day of the experiment, SPF chickens were housed in five groups of 20 chickens of comparable sex and weight. On the same day, each bird
was inoculated by the intranasal route with a standardized dose of the relevant virus (10
5 EID50 by bird, except for the ACU1 B88 virus which was
inoculated with 10
3.6 EID50 by bird). A group was kept as a mock-inoculated control receiving PBS only. See in Table S3 the summarized protocol of
the animal experiment. A) % cumulated mortality at 5 days post infection, B) BF to body weights ratio (%) at day 20 (n=7 to 10 chickens depending
on the group). The box plots show the median (horizontal line) flanked by the 2
nd and 3
rd quartile. The outer bars show the range of values. C) and D)
Histological lesion scoring at day 4 and 20, respectively (n=5 chickens per group). The outer bars show the range of values. E) VN titer at day 20 (in
log2, n=10 chickens per group). F) Virus titer at day 4 (in log10 EID50/gr, n=5 chickens per group). Treatments sharing the same lowercase letter do
not differ significantly according to the kruskal-Wallis test (BF to body weights ratio, lesion score, VN titer and virus titer) or according to the Chi-
squared test (% mortality), at the p#0.05 confidence level.
doi:10.1371/journal.pone.0028064.g003
Figure 4. Mean individual symptomatic index between 1 to 10 day post inoculation in chickens inoculated with mosaic
recombinant IBDV strains. The symptomatic index was calculated according a scale ranging from 0 to 3 with, with 0 meaning ‘‘lack of signs’’, 1
meaning ‘‘typical IBD signs (ruffled feathers) conspicuous in quiet bird only, the bird stimulated by a sudden change in environment (light, noise, or
vicinity of experiment observer) appears normal, motility is not reduced’’; 2 meaning ‘‘typical IBD signs conspicuous even when bird is stimulated,
dehydration is apparent, motility may be slightly reduced’’ and 3 standing for ‘‘typical severe IBD signs with prostration or death’’. mc88180 induced
significantly more morbidity than all other viruses from 3 to 9 DPI (p#0.0001 to p#0.003), whereas no significant difference in the severity of clinical
signs was observed between the groups receiving the other viruses or mock-inoculated., A simplified representation of the chimeric segments B
(based on the ones described in Figure 1) used in association with the segment A of 88180 to generate the indicated mosaic recombinant viruses is
shown.
doi:10.1371/journal.pone.0028064.g004
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which interaction could be modified by aa changes at polyprotein
positions 981 and 990. Finally, VP1 was also described to interact
with the 59 [20,63] and 39 NCRs [19], and the NCRs of Cu-1 and
88180 were indeed predicted to have differences in their secondary
structures (the 39 NCRs have been proved to be important for
IBDV replication and/or pathogenicity, both by the number of
their unpaired terminal cytosines and by their sub terminal hairpin
secondary structure [64,65]). Additional disrupted interactions
could affect VP4, which was described to trans-activate the
synthesis of VP1 [11], however the VP1 and VP4 domains
involved in these mechanisms are yet unknown.
Quite discrepantly as compared with ACU1B88, segment
incompatibility was not observed with the other reassortant virus,
A88BCU1, which induced bursal damage and the same virus titer
as mc88180 in BF at 4 DPI (as detected with a quantitative real-
time PCR targeted at the genome-specific minus strand of segment
A). Hence, a reassortant virus with a segment B derived from a
cell-culture-adapted IBDV strain (mcCu-1) replicated well in the
bursa. This is in contrast with previous reports studying reassortant
viruses derived from bursa- or cell-culture- propagated viruses
[37,38], which reports suggested that the RdRp of cell-culture-
adapted or bursa propagated viruses might have a better efficacy
for genome replication in cell culture or in the bursa, respectively.
To determine more precisely if specific regions of segment
BCU1 could be responsible for the reduced pathogenicity of
A88BCU1, we rescued five viruses with mosaic B segments and
tested them for their in vivo pathogenicity. The exchanged regions
within segment B of Cu-1 and 88180 were defined based on the
previously determined putative functional motifs within the IBDV
RdRp (Figure 1A). Such an approach has not been implemented
in Birnaviruses so far, in contrast with another model of RNA
viruses, Picornavirus, for which studies based on mosaic
polymerases derived from Coxsackie B3 and poliovirus type 1
demonstrated that different domains and several macromolecular
interactions are required for efficient delivery of the polymerase to
strand-specific replication complexes [66,67].
Our results with mosaic IBDV’s showed that, consistently with
the 88180 origin of their segment A, all recombinant viruses were
indeed pathogenic as they induced an atrophy of the BF,
significant histological lesions and an efficient antibody response.
Nevertheless, they all induced significantly less morbidity than
mc88180 and none of them caused mortality, although their
mosaic RdRps all retained the ability to replicate segment A of
88180 to the same extent, at least as detected with quantitative
RT-PCR at 4 DPI. These results show the discrepancy between
the virus replication (or fitness) and the pathogenicity of the mosaic
viruses. The low fitness and pathogenicity of the reassortant
ACU1B88 virus suggested that these two traits are both affected in
this virus. However, for A88BCU1 and the mosaic viruses their
fitness and virulence seem to be two separate traits. This is
somewhat comparable with what has been described for the foot-
and-mouth disease virus (FMDV), for which viral fitness and
virulence are two different virus traits [68]. Herrera et al showed
that a biological clone of FMDV with a high fitness and virulence
(cell killing capacity) that undergo plaque to plaque transfers had a
profound fitness loss, but with only a minimal decrease of
virulence. The authors showed that fitness-decreasing mutations
and virulence determinants are distinct and can follow different
evolutionary trajectories. For A88BCU1 and the mosaic viruses
the absence of link between the virus fitness and virulence remains
to be understood.
Our mosaic segment B experiments showed that the D1 and
especially the D2 domains play an important role in pathogenicity.
The reduced pathogenicity in viruses with heterologous D1 and
D2 domains (no mortality and significantly less morbidity
compared to mc88180) suggests that the compatibility between
D1 and D2 of the RdRp, (Finger 1 of D1 and Palm 2 and Thumb
of D2), which is affected when one out these two domains comes
from a different genetic background, is required for pathogenicity,
although the disruption does not interfere critically with the ability
of the viruses to replicate. Interestingly, the recombinant virus
incorporating only domain D2 of Cu-1 was milder than its D1
counterpart as it induced significantly less bursal atrophy and
histological lesions than B88[D1CU1] or mc88180. This suggests
that the Palm 2 and Thumb subdomains of the central domain
and C-terminal domain of the polymerase could be involved in
functions or interactions more important for pathogenicity.
Whether the more important role of D2 could be related to one
of the D2 aa differences between Cu-1 and 88180 that is located in
motif E of the RdRp is not yet known.
The same level of replication of the mosaic viruses compare to
mc88180 suggests that irrespective of their mosaic structure, all
RdRps interacted efficiently with the 39 and 59 NCRs originating
either from Cu-1 or from 88180. Hence, incompatibility of the
segment A- and segment B- NCRs was not the only cause for the
reduced pathogenicity of A88BCU1. However, the mirror
experiment remains to be performed and it cannot be excluded
that introducing partial or full length NCRs of Cu-1 in the B88
segment would also result in attenuation. Altogether, these results
can hardly compare with a previous study by Schro ¨der et al.
[69,70], showing that incorporating segment A NCRs derived
from an apathogenic serotype 2 IBDV strain into the genetic
context of a cell culture adapted serotype 1 virus reduced the in
vitro replication ability but only had a limited influence on bursal
lesions. The different impact of the NCR exchange is most
probably due to the secondary structures of the exchanged NCRs
being very different in the two studies (inter-serotypic exchange in
Schro ¨der et al., intra-serotypic exchange in the present work).
Finally, our results also showed that restoring the catalytic
domain Dc of 88180 (Palm 1, Finger 2 and beginning of Palm 2
subdomains of the central polymerase domain, containing the C,
A and B motifs [21,22]) in A88BCU1[Dc88], did not result in an
increased pathogenicity, even when it was also associated with the
Figure 5. Compared pathogenicity of mc88180, A88BCU1 and five recombinant viruses with mosaic segment B in five-week-old
SPF chickens (experiment iii). See in Table S1 and Figure 1 the genetic make up of the viruses with mosaic segment B and in Table S3 the
summarized protocol of the animal experiment. On the first day of the experiment, SPF chickens were housed in eight groups of 20 chickens of
comparable sex and weight. On the same day, each bird was inoculated by the intranasal route with a standardized dose of the relevant virus (10
5
EID50 by bird). A group was kept as a mock-inoculated control receiving PBS only. A) % cumulated mortality at 5 days post infection, B) BF to body
weights ratio (%) at day 21 (n=10 chickens per group). The box plots show the median (horizontal line) flanked by the 2
nd and 3
rd quartile. The outer
bars show the range of values. C) and D) Histological lesion scoring at day 4 and 21, respectively (n=5 chickens per group). The outer bars show the
range of values. E) VN titer at day 21 (in log2, n=8 to 10 chickens depending on the group). F) Virus titer at day 4 (in log10 EID50/gr, n=5 chickens per
group). Treatments sharing the same lowercase letter do not differ significantly according to the kruskal-Wallis test (BF to body weights ratio, lesion
score, VN titer and virus titer) or according to the Chi-squared test (% mortality), at the p#0.05 confidence level.
doi:10.1371/journal.pone.0028064.g005
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the central domain [21,22]) or D2 (Finger 2 and Thumb
subdomains of the central domain and C-terminal region
[21,22]). This suggests that VP1 positions 390–391 are not critical
for the RdRp activity, a finding which is consistent with these two
amino acid changes occurring in the ‘‘flexible region’’ connecting
the a1 helice and b1 tube in the Palm 1 region [21,23], and the A
motif where a single mutation was described to completely abolish
the RdRp activity [19].
Altogether, our results suggest that restoration of the full
pathogenicity of A88BCU1 could require i) either the incorpo-
ration of both the D1 and D2 of B88 (corresponding to the N-
terminal region and Finger 1 domain combined with the Palm 2,
Thumb subdomain and C-terminal region which included most of
the aa differences found between BCU1 and B88180), or ii)
possibly the restoration of the whole interaction domain of the
RdRp with VP3 [55], which almost corresponds to the central
domain of the polymerase (region overlapping the D1 and D2), or
iii) even the restoration of the whole B88 segment. This
demonstrates that different regions of the polymerase are essential
for IBDV pathogenicity, even without any impact on virus
replication. This is evocative of results reported in Picornaviruses,
in which complex interactions involving different domains of the
polymerase (that may be remote from the catalytic site) critically
contribute to the control of the fidelity of the polymerase, [71],
which in turn determines the genetic heterogeneity between the
quasi species in the viral population and may so modify the organ
tropism and pathogenicity of mutant viruses, although they
replicate to the same extent [72]. However, the mechanisms of
the reduction of pathogenicity in the recombinant IBDVs still
deserves further study. It cannot be ruled out that changes in the
early replicating cycle of the virus, before 4 days post inoculation,
or changes in the host immune responses at the early stages of
infection could be involved.
Materials and Methods
Ethics statement
All experiments were performed in agreement with national
regulations on animal welfare and animal experiments, according
to authorisations Nu22-4 and B-22-745-1, by Prefecture des Cotes-
d’Armor, France. The rescue of IBDV recombinant viruses and
their in vivo characterization (see below) were performed
according to authorization nu 3569 CA-I by the French
Commission for Genetically Modified Organisms.
Viruses and titration
IBDV strain 88180 [44], which is not adapted to cell culture,
was used as the parental strain for the construction of the
molecularly cloned 88180 virus (mc88180). The 89163 [47] and
Faragher 52/70 [73] IBDV strains were used as the references for
vvIBDV and classical IBDV strains, respectively. Virus suspen-
sions, produced from the bursa of inoculated chickens, were used
as inocula [47]. Inocula were titrated by inoculating serial ten-fold
dilutions (0.1 ml per egg, chorio allantoic membrane route, seven
eggs per dilution) to 9-to-10-day-old SPF eggs (Anses-Ploufragan/
Plouzane ´ laboratory). IBDV titers were calculated according to the
method of Reed & Muench (1938) [74] and expressed as median
embryo infectious doses (EID50).
Cells and chickens
Transfection experiments were performed using CEF derived
from SPF hen eggs (Anses-Ploufragan/Plouzane ´ laboratory) grown
in BHK-21 medium (Eurobio) supplemented with 0.3% Tryptose
Phosphate Broth (TPB), 5% foetal calf serum (FSC), 200 U/ml
antibiotics (streptomycin and penicillin) and 2 mg/ml fungizone.
Animal experiments were performed using five-to-seven-week-old
SPF White Leghorn chickens (Anses-Ploufragan/Plouzane ´ labo-
ratory) maintained in level 3 containment facilities in filtered-air
negative-pressure isolation units.
Sequencing of the full-length A and B segments of IBDV
strain 88180
Virus RNA was extracted from infected bursae as described
previously [75]. The coding regions of segments A and B were
sequenced using DNA fragments resulting from overlapping
reverse transcription (RT)- polymerase chain reactions (PCR) as
previously described [40], (oligonucleotide primers available upon
request). The 59 and 39 non coding regions (NCR) of segments A
and B were sequenced using the 59 Rapid Amplification of cDNAs
Ends (59RACE; Invitrogen) according the manufacturer’s proto-
col, using IBDV specific primers (the sequences of the oligonu-
cleotides used in this study are presented in supplementary Table
S2). For tailing, either dGTP or dCTP were used in independent
reactions, to determine the first or last nt of each extremity. The
tailed cDNA was then used for two consecutive PCR with nested
virus-specific primers and poly(C)- or poly(G)-primers (Table S2).
PCR products were purified as described above and were digested
with SpeI and EcoRI before ligation into the similarly cleaved
pMOSBLUE vector (Amersham Pharmacia Biotech). Transfor-
mation into competent One shot top10 E.coli (Invitrogen) of the
resulting plasmids followed by plasmid extraction (Qiagen) were
performed according to the manufacturer’s protocol. Sequencing
of the resulting cDNA clones was repeated until at least five clones
with the longest and same nucleotide sequence had been analysed.
Construction of full-length cDNA clones of the A and B
segments of 88180
Full-length single stranded cDNA copies of the A and B
segments of the 88180 strain were produced by RT as described
above, using oligonucleotide primers complementary to the 39 end
of the non-coding strand of segments A and B (=‘‘sense’’ primers)
(Table S2). The two sense primers contained 59 extensions
carrying the T7 promoter preceded by either the EcoRI or the
XbaI restriction site in primers designed for segments A or B,
respectively. The resulting cDNA was amplified in PCR reactions
performed as described above and based on primer pairs
consisting of the same sense primer as used for RT, combined
with an antisense primer with a 59 extension corresponding to a
cloning site (EcoRI or SmaI for segments A or B, respectively)
followed by a linearisation site (BsRGI for segment A, for segment
B the SmaI site used for cloning was also used as a linearisation
site). The conditions for the amplification of the full-length
segments were 35 cycles with denaturation at 95uC for 30 sec,
annealing for 45 sec (at 63.8uC or 61.7uC for segments A or B,
respectively) and extension at 72uC for 3 min. The PCR products
were purified as above. After enzymatic digestion of the PCR
products with EcoRI only (segment A) or XbaI and SmaI (segment
B), each segment was ligated to the similarly cleaved pUC18
vector. The resulting plasmids containing the segment A or B
sequence, designated as pA88 and pB88 for segments A and B,
respectively, were transformed into E. coli, purified and sequenced
on both strands as described above. Comparison of the full-length
A and B segment sequences derived from the bursa propagated
88180 virus (used as the reference sequences) with the corre-
sponding sequences of full-length cloned segment A and B (pA88
and pB88, respectively) was performed. Three unintended nt
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in pA88 and pB88, respectively. Mutation at nt 972 of pA88 was
non-silent and induced the mutation from a Glycine residue to a
Glutamic acid at position 281 and was conserved as a genetic tag
to differentiate the molecular clone mc88180 to 88180 virus. The
three other mutations, nts 3261, 3262 in pA88 and nt 2828 in
pB88, were missing cytosine nts in the 39 extremity of the 39 NCRs
and were corrected by site directed mutagenesis (Stratagene) with
specific primers as described in Table S2.
Construction of mosaic B segments by combining
different regions of the 88180 and Cu-1 genomes
Segment B of strain Cu-1 was obtained as pUCCu-1B, a
plasmid with a similar construction as pB88 [36]. To ensure
consistency in the names of the recombinant viruses, pUCCu-1B
was renamed pBCU1 in the present study. The putative functional
motifs and different domains of IBDV VP1 are shown in Figure 1
A and B respectively, together with the number and positions of aa
changes (coding regions) or nt changes (NCR) which differentiate
IBDV strains 88180 and Cu-1 (Figure 1 C). Based on these data,
the SspI, BstXI, PmLI and BsRGI conserved and unique restriction
sites (position shown at Figure 1 C) were selected to construct five
new plasmids derived from pB88 and pBCU1 (Figure 1 D and E).
The new constructs corresponded to the introduction into a
pBCU1 background of 88180 i) NCRs, ii) catalytic domain (Dc) ,
iii) both the NCRs and the Dc iv) the NCRs, the Dc and the 59
coding part of VP1 (D1) and v) the NCRs, the Dc and the 39
coding part of VP1 (D2) (Figure 1 E).
i) To construct a clone of segment B of Cu-1 with the NCRs of
88180, the SspI-BsRGI fragment (approximately 3.2 kbp) was first
excised from pB88 and replaced by its counterpart similarly
derived from pBCU1, to obtain pBCU1[NCR39 88]. Then, the
Ssp1-BstXI fragment of pB88 containing the 59NCR of 88180 was
subcloned into the similarly cleaved pBCU1[NCR39 88] to obtain
pBCU1[NCRs88], corresponding of the B segment of Cu-1 with
both the 59 and 39 NCRs of 88180. ii) and iii) The two mutations
typical of Dc of 88180 (Figure 1 C) were introduced into the
pBCU1 and pBCU1[NCRs88] plasmids by site-directed muta-
genesis using specific primers (Table S2), resulting in plasmids
pBCU1[Dc88] and pBCU1[NCRsDc88], respectively. iv) To
construct a clone of segment B of 88180 with D2 of Cu-1, the
BstXI-PmLI fragment of pB88 was subcloned into the similarly
cleaved pBCU1[NCRsDC88] to obtain pB88[D2CU1]. v)
Finally, to construct a full- length clone of segment B of 88180
with D1 of Cu-1, the PmLI-BsRGI fragment of pB88 was subcloned
into the similarly cleaved pBCU1[NCRsDC88] to obtain
pB88[D1CU1]. The sequences of the cloned or mutated regions
in pBCU1[NCRs88], pBCU1[Dc88] and pBCU1[NCRsDC88]
were checked and the sequences of the two last constructs,
plasmids pB88[D2CU1] and pB88[D1CU1], were completely
determined as described above.
Construction of a transcription/transfection plasmid
control
Two primers (sequence available upon request) complementary
to the 39 extremities of both the coding and non-coding strands of
the Green Florescent Protein gene (GFP, accession number
U57609) were used to amplify the GFP gene from the
pcDNA3.1/Zeo/GFP plasmid, in a PCR as described above.
The sense primer contained a 59 extension carrying the T7
promoter preceded by a PstI restriction site whereas the antisense
primer carried an XmaI site. After PstI-XmaI digestion, the PCR
product was cloned into the similarly cleaved POP24+(100A)
containing a polyA [76] to obtain the POP24+GFP100A plasmid
with the GFP gene under the control of the T7 promotor and a
polyA at the 39 extremity followed by an EcoRI restriction site. In
order to use the pUC18 plasmid (vector also used for the
construction of full-length cDNA clones of the A- and B- segments
of 88180 and Cu-1 strains) the PstI-EcoRI fragment of
POP24+GFP100A was subsequently ligated into the similarly
cleaved pUC18 plasmid to obtain the plasmid pT7GFPpolyA with
the GFP gene under the control of the T7 promotor and with the
EcoRI site used as linearisation site. Upon in vitro transcription this
plasmid generates a 1047 nt- long GFP cRNA ending with a
stretch of 100 A nucleotides, thus mimicking a polyadenylated
GFP mRNA.
In vitro transcription
The plasmids containing the full-length cDNA copies of the
native or chimeric IBDV genome segments or the GFP gene were
linearised with the restriction enzymes specific for the restriction
sites introduced at their 39 ends by the primers listed in Table S2.
The linearised plasmids were then used as templates for in vitro
transcription as described by Mundt and Vakharia (1996) [45]
with minor modifications as described by Zierenberg et al. (2004)
[36]. The in vitro transcription reaction was incubated for 1 h at
37uC. Synthesis of cRNA was confirmed by electrophoresis of 2 ml
of the reaction mixture in a 1% agarose gel and visualisation under
UV light.
Rescue of infectious IBDV
The capped cRNAs were used, in various combinations, for
transfection of CEF, as described previously [36,45]. Efficacy of in
vitro transcription/transfection was checked using pT7GFPpo-
ly100A by visualizing fluorescence under UV light in the
transfected cells at 48 h post transfection. Forty eight hours after
transfection, the cells were scraped and harvested with superna-
tants and inoculated by the intramuscular route to SPF chickens
(1 ml per bird, five birds per virus). Four days after inoculation, the
chickens were humanely killed and their bursae were harvested
and processed for virus isolation as described previously [47]. The
genetic make up and the references of the rescued viruses are
presented in Table S1. The genetic organization of the rescued
IBDV was checked for conformity with the expected construction
by nucleotide sequencing as described above.
Comparison of the antigenic profile of 88180 and
mc88180
The parent virus and its molecular clone were antigenically
characterized using a previously described antigen capture ELISA
(AC-ELISA) based on a panel of 8 different neutralizing anti-
IBDV Mabs detecting at least 6 epitopes of the VP2 protein
[44,77].
Animal experiments
Three experiments were performed to compare the pathoge-
nicity of i) 88180 and mc88180, ii) mc88180, mcCu-1 and the
corresponding reassortant viruses (A88 BCU1 and ACU1 B88)
and iii) mc88180 and the recombinant viruses derived from
mosaic B segments. A summary of each experimental design is
presented in supplementary Table S3. On the first day of the
experiments, SPF chickens were housed in groups of comparable
sex and weight and each chicken in each group was blood sampled
to check for seronegativity versus IBDV. On the same day, each
bird was inoculated by the intranasal route with a standardized
dose of the relevant virus (10
5 EID50 by bird except in experiment
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3.6 EID50 by
bird). In each experiment a group was kept as a mock-inoculated
control receiving PBS only. Clinical signs until 10 days post
inoculation (DPI) and cumulated mortality rates were measured.
Bursae and blood were sampled at different times post infections.
At each sampling date (Table S3), at least five birds per group were
weighed, humanely killed, necropsied and their bursae were
weighed for the subsequent calculation of the b/B ratio. At 4 DPI,
each bursa was cut in two halves after weighing, one half was kept
for histological examinations, the other was processed for the
preparation of a virus suspension (see below). All surviving birds at
the end of the experiments (Table S3) were humanely killed and
sampled for final serological and histological examinations of the
BF. The criteria analysed to assess the virus acute pathogenicity
were the intensity of the clinical signs, the mortality rate, the
IBDV-induced bursal atrophy (as measured by the b/B ratio), the
severity of the bursal histological lesions (see below) at 4 DPI and
at the end of experiment, the serological responses and the virus
titers in bursae harvested at 4 DPI (Table S3).
Symptomatic index
The intensity of the clinical signs was more precisely evaluated
in the last animal experiment by two different experimenters, using
individual marking of the birds (with coloured rings on legs) and a
symptomatic index that we specifically designed for the quotation
of IBD symptoms. This index ranges from 0 to 3, with 0 meaning
‘‘lack of signs’’, 1 meaning ‘‘typical IBD signs (ruffled feathers)
conspicuous in quiet bird only, the bird stimulated by a sudden
change in environment (light, noise, or vicinity of experiment
observer) appears normal, motility is not reduced’’; 2 meaning
‘‘typical IBD signs conspicuous even when bird is stimulated,
dehydration is apparent, motility may be slightly reduced’’ and 3
standing for ‘‘typical severe IBD signs with prostration or death’’.
In the third experiment, the mean symptomatic index (MSI) of the
surviving chickens was calculated daily from days 1 to 10 PI for
each inoculated virus.
Histological examinations
All histological examinations were performed by Dr M. Lagadic
(Maisons-Alfort, France). Bursae of Fabricius from the different
groups and from the different sampling times were examined
individually. The severity of the IBD-induced histological lesions
was quantified according to Skeeles’ scale for bursal lesion scores
(BLS) [78] which is based on five degrees: 0=no lesions; 1=mild
scattered cell depletion in a few follicles; 2=moderate, one-third
to one half of the follicles have atrophy or depletion of cells;
3=diffuse, atrophy of all follicles; and 4=acute inflammation and
acute necrosis typical of IBD.
IBDV neutralization test
Virus neutralization (VN) tests were performed in CEF, using
100 median tissue infective doses (TCID50) per well of the CT
IBDV strain (serotype 1), as described previously [77]. The VN
titer was expressed as log2 of the last dilution resulting in 100%
neutralization of the cytopathogenic effect. VN titers higher than
3.3 were considered as positive.
Quantification of virus RNA using quantitative RT-PCR
To easily quantify the virus in the virus suspension prepared
from the individual BF harvested at 4 DPI, we designed a
Taqman-based quantitative RT-PCR (qRT-PCR) for IBDV
segment A. A pair of suitable primers and a FAM-labelled
TAMRA-quenched probe (Table S2) were defined using the
Primer Express software (version 2.0, Applied Biosystems), in a
region of segment A (nts 3031–3092) that proved to be sufficiently
conserved in the alignment of pA88 and pACU1. The latter
plasmid corresponds to the cloned full-length segment A of Cu-1
and was obtained as pUCCu-1A [36]. For consistency grounds
pUCCu-1A was renamed pACU1 within the present study. The
qRT-PCR assay was designed with discrete RT and PCR steps
and targeted at the RT step the minus strand of the virus RNA
(present in mature IBDV particles only).
Briefly, a sample of BF (approximately 250 mg) was first ground
weight/vol in PBS. The supernatant harvested after centrifugation
at 12500 rpm for 10 min at +4uC was used for virus RNA
extraction (QIAmp viral RNA mini kit, Qiagen). The ‘‘high
capacity cDNA archive kit’’ (Applied Biosystems) was used for RT.
The RT mix (25 ml of denatured RNA, 16of RT buffer, 16of a
dNTP mixture, 400 nM of the sense primer, 125 units of
Multiscribe RT and RNase-free water to a final volume of
50 ml) was incubated at 37uC for 1 h. The PCR was then
performed according to the manufacturer’s protocol in a 96-well
format using the ABI PrismH 7000 Sequence Detection System
(Applied Biosystems). The reaction mixture (2.5 ml of the RT
product, 16of TaqMan Universal Master mix, 200 nM of probe,
150 nM of each primer and RNase-free water to a final volume of
25 ml) was subjected to the following thermocycling conditions:
50uC, 2 min; 95uC, 10 min; 40 cycles of 95uC, 15 sec, 60uC
1 min. All cDNA samples were tested in duplicates. Data were
analysed using the Sequence detection version 1.2.3 software
(Applied Biosystems). The final results were expressed as cycle
threshold (Ct) value, which is the cycle when the change in the
emission of fluorescence by the reporter dye significantly passes a
background threshold calculated by the software. Ct values were
converted into virus titers (EID50) using a standard curve prepared
from serial 10 fold dilutions of aliquoted and repeatedly titrated
reference suspensions of the F52/70, 89163, mc88180 or mcCu-1
viruses.
Statistical analysis
Percent values (morbidity and mortality rates) were compared
using the Chi squared test. Small series of quantitative values were
compared using the non parametric Kruskal-Wallis test for the
one-way analysis of variance. All statistical analysis were
performed using version 9.0 of the Systat software (Systat
Software, Inc.).
Submission of nucleotide sequences to databases
The full-length nt sequences for segments A and B of IBDV
strain 88180 were submitted to the EMBL database with accession
numbers AM111353 and AM111354, respectively.
Supporting Information
Table S1 References of the viruses rescued from the
different combinations of cloned segments A and B.
pACU1 and pBCU1 correspond to plasmids pUCCu-1A and
pUCCu-1B, respectively, described by Zierenberg et al. (2004)
[36].
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